NFA
VTVT icon

Nationwide Fund Advisors’s vTv Therapeutics VTVT Stock Holding History

Nationwide Fund Advisors’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-122
Closed -$29K – 2066
2017
Q3 		$29K Hold
122
– – ﹤0.01% 3083
2017
Q2 		$24K Hold
122
– – ﹤0.01% 3102
2017
Q1 		$32K Hold
122
– – ﹤0.01% 3045
2016
Q4 		$24K Hold
122
– – ﹤0.01% 3074
2016
Q3 		$35K Hold
122
– – ﹤0.01% 3087
2016
Q2 		$28K Hold
122
– – ﹤0.01% 3129
2016
Q1 		$25K Buy
122
+42
+53% +$10.5K ﹤0.01% 3082
2015
Q4 		$22K Buy
80
+57
+248% +$16K ﹤0.01% 3070
2015
Q3 		$6K Buy
+23
New +$8.01K ﹤0.01% 3220

Other funds holding VTVT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nationwide Fund Advisors's VTVT Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of vTv Therapeutics (VTVT) in Q4 2017, closing a stake of 122 shares — an estimated $29K sold.

Nationwide Fund Advisors first reported a position in VTVT in Q3 2015 and held it in 9 quarters. The position peaked at $35K in Q3 2016. 44 funds tracked by Wall St. Rank hold VTVT as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining vTv Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 122 vTv Therapeutics shares in Q4 2017, an estimated $29K.
  • Nationwide Fund Advisors first reported a position in vTv Therapeutics in Q3 2015 and held it in 9 quarters.
  • Nationwide Fund Advisors's vTv Therapeutics position peaked at $35K in Q3 2016.
  • 44 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.